Gerrit-Jan Koomen

Title: Gerrit-Jan Koomen: Innovator in Purine Derivatives

Introduction

Gerrit-Jan Koomen is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of purine derivatives. With a total of 2 patents, his work focuses on selective adenosine antagonists and their applications.

Latest Patents

Gerrit-Jan Koomen's latest patents include innovative compounds that have the potential to impact medical treatments. One of his patents relates to 2-substituted-6-trifluoromethyl purine derivatives as selective adenosine antagonists, specifically targeting adenosine-A receptor antagonists. This invention also encompasses methods for the preparation of these compounds and novel intermediates useful for their synthesis. Another patent involves 2-substituted-1-deaza purine derivatives, which serve as adenosine receptor modulating agents. Similar to the first, this patent details methods for preparation and the synthesis of these purine derivatives.

Career Highlights

Gerrit-Jan Koomen is currently associated with Solvay Pharmaceuticals B.V., where he continues to innovate in the pharmaceutical sector. His expertise in purine chemistry has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Gerrit-Jan has collaborated with esteemed colleagues such as Jacobus A J Den Hartog and Martinus J Wanner. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Gerrit-Jan Koomen's contributions to the field of purine derivatives exemplify his commitment to advancing pharmaceutical science. His patents reflect a deep understanding of adenosine receptor modulation, which may lead to significant medical advancements.